The consortium run by the best universities of South Korea, the University of Yonsei and the Seul National University will begin a national project promoting the early detection of autism spectrum disorders in this country.
Supported by the National Center for Mental Health and the Ministry of Health and Social Welfare, the project received 9.2 billion wins ($ 6.6 million) in government financing.
According to the media message, the project aims to develop digital and medical devices powered by artificial intelligence for autism screening, which are directed to spending by 2028. The devices will be conducted by algorithms based on data from Kohort 1200 infants and juvenile children under 48 months. In addition, the apply of an pioneering marking of a medical device from the Ministry of Food and Drug Safety will be used.
Why does it matter
A recent article was recorded General growth In ASD cases among Korean children and adolescents in 2011–2021. It is estimated that the occurrence of ASD defined by DSM-5 2.20%. This trend may require calibration of a timelier strategy and more effective prevention and care of children with autism.
However, current approaches to ASD diagnosis, according to the consortium directed by Yonsei-SNU, are largely dependent on the results of specialists and subjective observations of carers, which often make them inconsistent and lacked objectivity.
“Based on artificial intelligence [ASD] A testing test that will be developed as part of this project will be an opportunity to change the paradigm of the early diagnosis of autism and treatment, “explained Chun Geun-Ah, a professor at the Yonsei University Severnce Hospital hospital and main project researcher.
“The consortium will set a basis for overcoming diagnosis restrictions [ASD] And it led to better treatment results, “said Kim Boong-Nyeon, a professor and investigator SNUH) and investigators.
The consortium includes several main hospitals, such as the Gangnam Severnce Hospital hospital, EWHA Womans University Hospital in Seoul and Mokdong and the Seul St. hospital Mary’s and digital health companies, including Huraypositive and Adotcure.
Greater trend
In 2023, Snih opened Living laboratory to collect data that will be used to develop models based on the algorithm for detection and personalization of ASD treatment. The laboratory, also supported by NCMH, serves as the basis of recent digital therapeutic and discoveries of autism biomarkers.
AI has noted growing applications in screening and ASD treatment. Eartec diagnostics In the United States he is the main developer in this space. He received regulatory approval for a tool for supporting autism decision in 2022.
Meanwhile, in Japan, recent research has used sight tracking technology to show how predictable motor stimuli can be potentially used as Behavioral marker for autism.